Immix Biopharma, Inc. IMMX Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s lessee operating lease liability undiscounted excess amount?
- Immix Biopharma, Inc. (IMMX) reported lessee operating lease liability undiscounted excess amount of $356.67K in Q1 2026.
- How has Immix Biopharma, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
- Immix Biopharma, Inc.'s lessee operating lease liability undiscounted excess amount decreased by 18.3% year-over-year, from $436.55K to $356.67K.